Kaveh Karimzad, MD
Department of Cardiology, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Interventional Cardiologist, University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1999 | Shahid Beheshti University of Medical Sciences, Tehran, IRN, MD, Medicine |
Postgraduate Training
| 2011-2012 | Clinical Fellowship, Clinical Cardiac Electrophysiology, University of Texas, Houston, TX |
| 2008-2011 | Clinical Fellowship, Cardiovascular Disease, University of Texas, Houston, TX |
| 2006-2008 | Clinical Residency, Internal Medicine, University of Texas, Houston, TX |
| 2005-2006 | Clinical Internship, Internal Medicine, Louisiana State University, New Orleans, LA |
Board Certifications
| 2013 | American Board of Internal Medicine Clinical Cardiac Electrophysiology |
| 2011 | American Board of Internal Medicine Cardiovascular Disease |
| 2010 | National Board of Echocardiography |
| 2008 | American Board of Internal Medicine |
Experience & Service
Administrative Appointments/Responsibilities
Director of Electrophysiology, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - Present
Director of Cardiac Device Clinic, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - Present
Chief Fellow, Department of Cardiology, University of Texas, Houston, TX, 2010 - 2011
Military or Other Governmental Service
Medical Practice, Military Service Obligation, Ghazvin, Iran, 1999 - 2001
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Sudasena D, Balanescu DV, Donisan T, Hassan S, Palaskas N, Kim P, Karimzad K, Lopez-Mattei J, Arain S, Gould KL, Iliescu C. Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib. Cardiovasc Toxicol 19(4):382-387, 2019. e-Pub 2018. PMID: 30543051.
- Palaskas N, Morgan J, Daigle T, Banchs J, Durand JB, Hong D, Naing A, Le H, Hassan SA, Karimzad K, Mouhayar E, Kim P, Lopez-Mattei J, Thompson K, Yusuf SW, Iliescu C. Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors. Am J Cardiol 123(8):1351-1357, 2019. e-Pub 2019. PMID: 30765065.
- Liu VY, Agha AM, Lopez-Mattei J, Palaskas N, Kim P, Thompson K, Mouhayar E, Marmagkiolis K, Hassan SA, Karimzad K, Iliescu CA. Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field. Front Cardiovasc Med 5:48, 2018. e-Pub 2018. PMID: 29868614.
- Reddy N, Moudgil R, Lopez-Mattei JC, Karimzad K, Mouhayar EN, Somaiah N, Conley AP, Patel S, Giza DE, Iliescu C. Progressive and Reversible Conduction Disease with Checkpoint Inhibitors. Can J Cardiol Ref. No.: CJC-D-17-00514R2(10):1335.e13-1335.e15, 2017. e-Pub 2017. PMID: 28822650.
- Giza DE, Boccalandro F, Lopez-Mattei J, Iliescu G, Karimzad K, Kim P, Iliescu C. Ischemic Heart Disease: Special Considerations in Cardio-Oncology. Curr Treat Options Cardiovasc Med 19(5):37, 2017. PMID: 28425056.
- Munoz E, Iliescu G, Vejpongsa P, Charitakis K, Karimzad K, Lopez-Mattei J, Yusuf SW, Marmagkiolis K, Iliescu C. Takotsubo Stress Cardiomyopathy: "Good News" in Cancer Patients?. J Am Coll Cardiol 68(10):1143-4, 2016. PMID: 27585514.
- Loghin C, Karimzadehnajar K, Ekeruo IA, Mukerji SS, Memon NB, Kantharia BK. Outcome of pulmonary vein isolation ablation for paroxysmal atrial fibrillation: predictive role of left atrial mechanical dyssynchrony by speckle tracking echocardiography. J Interv Card Electrophysiol 39(1):7-15, 2014. e-Pub 2013. PMID: 24310816.
- Javadi S, Mosaffa N, Karimzadeh K. The Effect of Glycation of Culture Medium on Phagocytic and Respiratory Burst of Peritoneal Macrophages from Balb/C mice. Immunology 1:179-185, 2004.
Abstracts
- Lee M, Dayah, T, Balanescu D, Donisan T, Karimzad K, Hakeem A, Boone D, Palaskas N, Lopez-Mattei J, Kim P, Durand JB, Song J, Balanescu SM, Yang EH, Herrmann J, Marmagkioli K, Toutouzas K, Johnson N, Iliescu C. Reclassification of Treatment Strategy with Fractional Flow Reserve in Cancer Patients with Coronary Artery Disease. Journal American College of Cardiology 12(4, Suppl S):100.56, 2019.
- Karimzad, K. Left Atrial Dyssynchrony as a Predictor of Postoperative Atrial Fibrillation in Cancer Patients. International Academy of Cardiology, 2016.
- JD Grant, MD, A Dougherty, MD, K Karimzad, MD, DR Gomez, MD, MA Rozner, PhD, MD. (S026) A Novel Method for Detecting Serious Cardiac Device Errors in Patients Receiving Radiotherapy Using Daily Pulse Checks. Cancer Network, 2015.
- Karimzad, K. Assessment of Left Atrial Mechanical Dyssynchrony with Speckle Tracking Predicts Atrial Fibrillation Recurrence after Catheter Ablation. Heart Rhythm Society, 2012.
- Karimzad, K. Diastolic Strain Rate and Doppler Parameters are Associated with Scar Size and Transmurality in ST-Elevation Myocardial Infarction Patients. International Academy of Cardiology, 2011.
- Karimzad, K. Position of Left Ventricular Lead and the Outcome of Cardiac Resynchronization Therapy: Role of Echocardiographic Deformation Imaging. Europace, 2011.
- Karimzad, K. FFR in Cancer Patients. (SCAI) The Society for Cardiovascular Angiography and Interventions Foundation, 2011.
- Karimzadehnajar K, Azpura F, Shezad S, Durand JB, Iliescu C. Fractional Flow Reserve: Less is sometimes more in cancer patients. The Society for Cardiovascular Angiography and Interventions Scientific Sessions, 2011.
Book Chapters
- Karimzad, K. Common arrhythmias / Device management in patients with Cancer. In: Cancer and Cardiovascular Disease - A Concise Clinical Atlas. Springer International Publishing AG, Cham.
- Karimzad K. CIEDs Management During Radiation Therapy. In: Cancer and the Heart. 3rd: United States.
- Kim P, Zarifa A, Salih M, Karimzad K. Oncologic Critical Care. In: Arrhythmias in the Cancer Patient. Springer: United States of America.